Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AXSM | AMGN | GILD | CELG | VRTX |
| Company | Axsome Thera | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 71.53 | 272.14 | 67.09 | 108.01 | 404.00 |
| High | 74.34 | 274.08 | 67.68 | 108.59 | 406.86 |
| Low | 70.30 | 271.05 | 67.06 | 107.27 | 403.47 |
| Last | 73.57 | 274.03 | 67.16 | 108.24 | 404.63 |
| Change | +2.47 | +2.12 | +0.21 | +0.11 | +4.71 |
| % Change | +3.47% | +0.78% | +0.31% | +0.10% | +1.18% |
| Volume | 334,214 | 812,328 | 1,950,964 | 191,230,496 | 330,993 |
| 20-Day Average Volume | 549,899 | 2,130,211 | 6,166,422 | 16,188,930 | 939,684 |
| Previous Close | 71.10 | 271.91 | 66.95 | 108.13 | 399.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 72.37 | 271.98 | 69.35 | 108.17 | 404.18 |
| 20-Day Raw Stochastic | 60.38% | 45.87% | 17.00% | 63.25% | 46.12% |
| 20-Day Relative Strength | 49.65% | 48.62% | 34.08% | 64.69% | 48.02% |
| Weighted Alpha | +1.36 | +11.41 | -20.49 | +46.30 | +17.80 |
| Today's Opinion | 40% Sell | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Previous Opinion | 56% Sell | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 40% Buy | 8% Buy | 88% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.91% since 04/16/24 | +2.95% since 04/16/24 | -0.08% since 04/16/24 | -1.97% since 11/13/19 | +2.76% since 04/16/24 |
| Low | 65.50 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 74.34 on 04/23/24 | 274.08 on 04/23/24 | 67.68 on 04/23/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -7.94% since 03/22/24 | -0.98% since 03/22/24 | -7.38% since 03/22/24 | +5.14% since 10/18/19 | -2.55% since 03/22/24 |
| Low | 65.50 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 83.89 on 03/25/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -17.05% since 01/23/24 | -11.76% since 01/23/24 | -15.38% since 01/23/24 | +13.63% since 08/20/19 | -7.88% since 01/23/24 |
| Low | 65.50 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 98.40 on 02/12/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +19.75% since 10/23/23 | +0.15% since 10/23/23 | -13.29% since 10/23/23 | +14.14% since 05/20/19 | +10.17% since 10/23/23 |
| Low | 55.02 on 11/13/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 98.40 on 02/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,368,291 | 145,845,984 | 83,357,904 | 77,035,920 | 103,362,928 |
| Shares Outstanding, K | 47,374 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 270,600,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -239,240,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 71,530,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -98,650,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.13 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 02/20/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/06/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 9.93 | 10.99 | 29.34 |